|
|
News Breaks
|
November 5, 2009
|
| 08:18 EDT |  | MDT |
| theflyonthewall.com: | Medtronic upgraded and added to Focus List at Credit Suisse | | As reported earlier, Credit Suisse upgraded Medtronic to Outperform from Neutral. The firm also added the stock to its Focus List and raised its target on shares to $49 from $41. Credit Suisse believes Medtronic's base business is stabilizing and the stock's risk/reward is compelling. :theflyonthewall.com |
|
|
News For MDT From The Last 14 Days Check below for free stories on MDT the last two weeks.
There are 9 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
February 11, 2012
|
| 12:53 EDT |  | MDT |
| theflyonthewall.com: | Medtronic seeks interest payment and royalties from NuVasive, Bloomberg says | | Medtronic (MDT) filed a request in San Diego federal court seeking payment from NuVasive (NUVA) for interest on a past jury verdict and royalty payments form patent infringements, reports Bloomberg. Reference Link :theflyonthewall.com |
|
|
February 8, 2012
|
| 08:02 EDT |  | MDT |
| theflyonthewall.com: | Medtronic stent led to 90% freedom from reinterventions at 12 months in study |
 Subscribe for More Information :theflyonthewall.com |
|
|
February 7, 2012
|
| 10:33 EDT |  | MDT |
| theflyonthewall.com: | Argus Research's healthcare analyst holds a conference call | | Senior Healthcare Analyst Toung discusses healthcare and growth ideas for 2012 on an Analyst/Industry conference call. Relevant covered companies ABC, ABT, AET, BAX, BDX, BSX, CAH, CHSI, CI, ESRX, HMA, HOLX, HUM, IART, JNJ, MCK, MDT, MHS, STJ, SYK, UNH and ZMH may be included on the Analyst/Industry conference call to be held on February 8 at 11 am. :theflyonthewall.com |
|
|
February 3, 2012
|
| 07:39 EDT | | MDT |
|
|
February 2, 2012
|
| 14:05 EDT | | MDT |
| theflyonthewall.com: | FDA and industry reach agreement in principle on medical device user fees | | The FDA and representatives from the medical device industry have reached an agreement in principle on proposed recommendations for the third reauthorization of a medical device user fee program. The recommendations would authorize the FDA to collect $595M in user fees over five years, plus adjustments for inflation. Details of the agreement, such as the fee structure, are expected to be finalized soon. :theflyonthewall.com |
| | 12:15 EDT | | MDT |
| | 07:23 EDT | | MDT |
|
|
February 1, 2012
|
| 09:05 EDT | | MDT |
| | 08:00 EDT | | MDT |
|
|
|
|
|
